Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.
2.

Lysophosphatidylserine-induced functional switch of human cytochrome P450 1A2 and 2E1 from monooxygenase to phospholipase D.

Cho EY, Yun CH, Chae HZ, Chae HJ, Ahn T.

Biochem Biophys Res Commun. 2008 Nov 21;376(3):584-9. doi: 10.1016/j.bbrc.2008.09.023. Epub 2008 Sep 16.

PMID:
18801337
3.

A double transgenic mouse model expressing human pregnane X receptor and cytochrome P450 3A4.

Ma X, Cheung C, Krausz KW, Shah YM, Wang T, Idle JR, Gonzalez FJ.

Drug Metab Dispos. 2008 Dec;36(12):2506-12. doi: 10.1124/dmd.108.022723. Epub 2008 Sep 17.

4.

Phospholipase A(2), reactive oxygen species, and lipid peroxidation in CNS pathologies.

Adibhatla RM, Hatcher JF.

BMB Rep. 2008 Aug 31;41(8):560-7. Review.

5.

The pregnane X receptor: from bench to bedside.

Ma X, Idle JR, Gonzalez FJ.

Expert Opin Drug Metab Toxicol. 2008 Jul;4(7):895-908. doi: 10.1517/17425255.4.7.895 . Review.

6.

Biomarkers of acute kidney injury.

Edelstein CL.

Adv Chronic Kidney Dis. 2008 Jul;15(3):222-34. doi: 10.1053/j.ackd.2008.04.003. Review.

7.

Function of reactive oxygen species during animal development: passive or active?

Covarrubias L, Hernández-García D, Schnabel D, Salas-Vidal E, Castro-Obregón S.

Dev Biol. 2008 Aug 1;320(1):1-11. doi: 10.1016/j.ydbio.2008.04.041. Epub 2008 May 11. Review.

8.

Investigation of rifampicin-induced hepatotoxicity in rat hepatocytes maintained in gel entrapment culture.

Shen C, Cheng X, Li D, Meng Q.

Cell Biol Toxicol. 2009 Jun;25(3):265-74. doi: 10.1007/s10565-008-9076-8. Epub 2008 May 22.

PMID:
18496758
9.

Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4.

Zhou SF.

Curr Drug Metab. 2008 May;9(4):310-22. Review.

PMID:
18473749
10.

Up-regulation of the glutathione S-transferase system in human liver by polycyclic aromatic hydrocarbons; comparison with rat liver and lung.

Pushparajah DS, Umachandran M, Plant KE, Plant N, Ioannides C.

Mutagenesis. 2008 Jul;23(4):299-308. doi: 10.1093/mutage/gen012. Epub 2008 Apr 3.

PMID:
18388359
11.
12.

The current state of serum biomarkers of hepatotoxicity.

Ozer J, Ratner M, Shaw M, Bailey W, Schomaker S.

Toxicology. 2008 Mar 20;245(3):194-205. doi: 10.1016/j.tox.2007.11.021. Epub 2007 Dec 5. Review.

PMID:
18291570
13.
14.
15.

Ontogeny of human hepatic cytochromes P450.

Hines RN.

J Biochem Mol Toxicol. 2007;21(4):169-75. Review.

PMID:
17936930
16.

Lipoprotein-associated phospholipase A2: a new biomarker for cardiovascular risk assessment and potential therapeutic target.

Carlquist JF, Muhlestein JB, Anderson JL.

Expert Rev Mol Diagn. 2007 Sep;7(5):511-7. Review.

PMID:
17892360
17.

LC-MS-based metabolomics in drug metabolism.

Chen C, Gonzalez FJ, Idle JR.

Drug Metab Rev. 2007;39(2-3):581-97. Review.

18.

Reactive oxygen species and superoxide dismutases: role in joint diseases.

Afonso V, Champy R, Mitrovic D, Collin P, Lomri A.

Joint Bone Spine. 2007 Jul;74(4):324-9. Epub 2007 May 24. Review.

PMID:
17590367
19.

Acetaminophen-induced hepatotoxicity in a glutathione synthetase-deficient patient.

Tokatli A, Kalkanoğlu-Sivri HS, Yüce A, Coşkun T.

Turk J Pediatr. 2007 Jan-Mar;49(1):75-6.

PMID:
17479648
20.

Role of CYP3A and CYP2E1 in alcohol-mediated increases in acetaminophen hepatotoxicity: comparison of wild-type and Cyp2e1(-/-) mice.

Wolf KK, Wood SG, Allard JL, Hunt JA, Gorman N, Walton-Strong BW, Szakacs JG, Duan SX, Hao Q, Court MH, von Moltke LL, Greenblatt DJ, Kostrubsky V, Jeffery EH, Wrighton SA, Gonzalez FJ, Sinclair PR, Sinclair JF.

Drug Metab Dispos. 2007 Jul;35(7):1223-31. Epub 2007 Mar 28.

Supplemental Content

Support Center